Heparin Market Size, Share & Trends Analysis Report By Type (Low Molecular Weight Heparin, Unfractionated Heparin), By Route Of Administration, By Application, By End-use, By Source, By Region, And Segment Forecasts, 2022 - 2030

Heparin Market Growth & Trends

The global heparin market size is expected to reach USD 9.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.4% from 2022 to 2030. The increasing geriatric population and heightened demand for transfusions are key factors propelling the market growth. Moreover, the outbreak of the COVID-19 has further propelled market growth. For instance, as per The Lancet Journal in 2022, the demand for heparin exacerbated attributable to its use in COVID-19 patients for thromboprophylaxis.

Increasing demand for blood components, transfusion, and plasma derivatives in the treatment of infectious diseases are expected to drive the market. For instance, according to American Red Cross in 2022, around 16 million blood components are transfused each year in the U.S. Furthermore, the surge in the number of surgeries that were delayed due to the COVID-19 pandemic has further escalated the demand for heparin for blood-clot prevention.

The growing geriatric population is estimated to fuel the market growth. According to United Nations, it was estimated that, in 2020, there were around 727 million people with ages above 60 years worldwide. In addition, the percentage share of the aged population above 65 years is estimated to increase from 9.3% to 2020 to 16% in 2050. The geriatric population has a higher rate of complex surgeries and thus is anticipated to propel the demand for heparin as an anticoagulant, as this population has a significantly higher rate of developing blood clots and related conditions such as deep vein thrombosis.

Growing number of surgeries is a key factor accelerating the demand for whole blood and transfusions. For instance, the annual number of major surgeries performed globally has reached 310 million, 40 to 50 million surgeries performed in the U.S., and around 20 million were performed in Europe in 2020. These surgeries are projected to escalate the demand for heparin.

The competitive rivalry in the marketplace is expected to be moderate due to changing dynamics towards oral anticoagulants. The involvement of players in discovering novel routes of administration for anticoagulants such as heparin is expected to change the market scenario over the forecast period. Rising number of players offering generics also increases competitive rivalry.

Heparin Market Report Highlights

  • The Low Molecular Weight Heparin (LMWH) segment held the largest revenue share in 2021 owing to its high prescription rate and demand
  • The subcutaneous route of administration segment held the largest revenue share in 2021 owing to its cost-effective nature and easier procedure for administration
  • The coronary artery disease segment dominated the market in 2021 owing to the rising incidence of coronary artery disease and increased use of heparin injection in hospitalized patients
  • The outpatient segment is expected to hold the largest revenue share in 2021 owing to the initiatives undertaken by hospitals for outpatient services and increased preference of patients for outpatient treatment
  • Porcine derived heparin is expected to dominate the market due to its use in the production of low molecular weight heparin
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the growing establishment of healthcare, and a large population base
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Heparin Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Growing demand for whole blood and blood components transfusion
3.2.1.3 Increasing geriatric population
3.2.1.4 High usage of plasma in pharmaceutical industry
3.2.2 Market restraint analysis
3.2.2.1 Risk of blood transmitted diseases and increasing number of blood substitutes
3.2.2.2 Emerging oral anticoagulants
3.3 Penetration & Growth Prospect Mapping
3.4 Heparin: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
Chapter 4 Heparin Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Heparin Market, by Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Low Molecular Weight Heparin (LMWH)
4.5.1.1 Low molecular weight heparin market, 2018 - 2030 (USD Million)
4.5.2 Ultra-Low Molecular Weight Heparin (ULMWH)
4.5.2.1 Ultra-Low molecular weight heparin market, 2018 - 2030 (USD Million)
4.5.3 Unfractionated Heparin
4.5.3.1 Unfractionated heparin market, 2018 - 2030 (USD Million)
Chapter 5 Heparin Market Segment Analysis, By Route of Administration, 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Route of Administration Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Heparin Market, by Route of Administration, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Intravenous
5.5.1.1 Intravenous market, 2018 - 2030 (USD Million)
5.5.2 Subcutaneous
5.5.2.1 Subcutaneous market, 2018 - 2030 (USD Million)
Chapter 6 Heparin Market Segment Analysis, By Application, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Heparin Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Venous Thromboembolism
6.5.1.1 Venous thromboembolism market, 2018 - 2030 (USD Million)
6.5.2 Coronary Artery Disease
6.5.2.1 Coronary artery disease market, 2018 - 2030 (USD Million)
6.5.3 Renal Impairment
6.5.3.1 Renal impairment market, 2018 - 2030 (USD Million)
6.5.4 Atrial Fibrillation
6.5.4.1 Atrial fibrillation market, 2018 - 2030 (USD Million)
6.5.5 Others
6.5.5.1 Others market, 2018 - 2030 (USD Million)
Chapter 7 Heparin Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2021 & 2030
7.3 Segment Dashboard
7.4 Global Heparin Market, by End-use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Outpatient
7.5.1.1 Outpatient market, 2018 - 2030 (USD Million)
7.5.2 Inpatient
7.5.2.1 Inpatient market, 2018 - 2030 (USD Million)
Chapter 8 Heparin Market Segment Analysis, By Source, 2018 - 2030 (USD Million)
8.1 Definition and Scope
8.2 Source Market Share Analysis, 2021 & 2030
8.3 Segment Dashboard
8.4 Global Heparin Market, by Source, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Porcine
8.5.1.1 Porcine market, 2018 - 2030 (USD Million)
8.5.2 Bovine
8.5.2.1 Bovine market, 2018 - 2030 (USD Million)
8.5.3 Others
8.5.3.1 Others market, 2018 - 2030 (USD Million)
Chapter 9 Heparin Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
9.1 Definition & Scope
9.2 Regional Market Share Analysis, 2021 & 2030
9.3 Regional Market Dashboard
9.4 Regional Market Snapshot
9.5 SWOT Analysis
9.5.1 North America
9.5.2 Europe
9.5.3 Asia Pacific
9.5.4 Latin America
9.5.5 Middle East and Africa
9.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
9.6.1 North America
9.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
9.6.1.2 U.S.
9.6.1.2.1 U.S. heparin market, 2018 - 2030 (USD Million)
9.6.1.3 Canada
9.6.1.3.1 Canada heparin market, 2018 - 2030 (USD Million)
9.6.2 Europe
9.6.2.1 Europe heparin market, 2018 - 2030 (USD Million)
9.6.2.2 U.K.
9.6.2.2.1 U.K. heparin market, 2018 - 2030 (USD Million)
9.6.2.3 Germany
9.6.2.3.1 Germany heparin market, 2018 - 2030 (USD Million)
9.6.2.4 Spain
9.6.2.4.1 Spain heparin market, 2018 - 2030 (USD Million)
9.6.2.5 France
9.6.2.5.1 France heparin market, 2018 - 2030 (USD Million)
9.6.2.6 Italy
9.6.2.6.1 Italy heparin market, 2018 - 2030 (USD Million)
9.6.2.7 Russia
9.6.2.7.1 Russia heparin market, 2018 - 2030 (USD Million)
9.6.3 Asia Pacific
9.6.3.1 Asia Pacific heparin market, 2018 - 2030 (USD Million)
9.6.3.2 Japan
9.6.3.2.1 Japan heparin market, 2018 - 2030 (USD Million)
9.6.3.3 China
9.6.3.3.1 China heparin market, 2018 - 2030 (USD Million)
9.6.3.4 India
9.6.3.4.1 India heparin market, 2018 - 2030 (USD Million)
9.6.3.5 South Korea
9.6.3.5.1 South Korea heparin market, 2018 - 2030 (USD Million)
9.6.3.6 Australia
9.6.3.6.1 Australia heparin market, 2018 - 2030 (USD Million)
9.6.3.7 Singapore
9.6.3.7.1 Singapore heparin market, 2018 - 2030 (USD Million)
9.6.4 Latin America
9.6.4.1 Latin America heparin market, 2018 - 2030 (USD Million)
9.6.4.2 Brazil
9.6.4.2.1 Brazil heparin market, 2018 - 2030 (USD Million)
9.6.4.3 Mexico
9.6.4.3.1 Mexico heparin market, 2018 - 2030 (USD Million)
9.6.4.4 Argentina
9.6.4.4.1 Argentina heparin market, 2018 - 2030 (USD Million)
9.6.5 MEA
9.6.5.1 MEA heparin market, 2018 - 2030 (USD Million)
9.6.5.2 South Africa
9.6.5.2.1 South Africa heparin market, 2018 - 2030 (USD Million)
9.6.5.3 Saudi Arabia
9.6.5.3.1 Saudi Arabia heparin market, 2018 - 2030 (USD Million)
9.6.5.4 UAE
9.6.5.4.1 UAE heparin market, 2018 - 2030 (USD Million)
Chapter 10 Heparin Market - Competitive Analysis
10.1 Recent Developments & Impact Analysis, by Key Market Participants
10.1.1 Ansoff matrix
10.1.2 Heat map analysis
10.1.3 Major Deals and Strategic Alliances Analysis
10.1.3.1 Joint Ventures
10.1.3.2 Licensing Agreements
10.1.3.3 Product Launches
10.1.3.4 Conferences and Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.3 Vendor Landscape
10.3.1 List of key distributors and channel partners
10.3.2 Key customers
10.4 Public Companies
10.4.1 Competitive Dashboard Analysis
10.4.2 Market Differentiators
10.5 Private Companies
10.5.1 List of key emerging companies
10.6 Company Profiles
10.6.1 GlaxoSmithKline plc (GSK)
10.6.1.1 Company overview
10.6.1.2 Financial performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic Initiatives
10.6.2 Pfizer Inc.
10.6.2.1 Company overview
10.6.2.2 Financial performance
10.6.2.3 Product benchmarking
10.6.2.4 Strategic Initiatives
10.6.3 LEO Pharma A/S
10.6.3.1 Company overview
10.6.3.2 Financial performance
10.6.3.3 Product benchmarking
10.6.3.4 Strategic Initiatives
10.6.4 Sanofi
10.6.4.1 Company overview
10.6.4.2 Financial performance
10.6.4.3 Product benchmarking
10.6.4.4 Strategic Initiatives
10.6.5 Dr. Reddy’s Laboratories Ltd.
10.6.5.1 Company overview
10.6.5.2 Financial performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic Initiatives
10.6.6 Aspen Holdings
10.6.6.1 Company overview
10.6.6.2 Financial performance
10.6.6.3 Product benchmarking
10.6.6.4 Strategic Initiatives
10.6.7 B. Braun Medical Inc.
10.6.7.1 Company overview
10.6.7.2 Financial performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Fresenius SE & Co. KGaA
10.6.8.1 Company overview
10.6.8.2 Financial performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 Sandoz (Novartis AG)
10.6.9.1 Company overview
10.6.9.2 Financial performance
10.6.9.3 Product benchmarking
10.6.9.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings